RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. CR Biotech
C

CR Biotech portfolio

CR Biotech has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $153M.
Latest deal: Arthrosi Therapeutics · Oct 8, 2025.
About this page

Its most recent investment on record is Arthrosi Therapeutics's $153M Series B+ round in October 2025, alongside HM Venture Partners, Highlight Capital, Prime Eight Capital and 2 others. That company is in Health and bio.

What CR Biotech invests in

How CR Biotech invests

StageDealsCapital in rounds
Series B+ 1 100%$153M

CR Biotech portfolio companies

CompanyRound with CR BiotechTotal raisedLatest raise
AArthrosi Therapeutics
Health and bio
Series B+ · $153M$228MOct 8, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name CR Biotech. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists CR Biotech, which is a subset of its real portfolio. API: /api/v1/investors/cr-biotech (get a free API key). More: the most active VC firms and new venture capital funds.